As community care teams work to provide equitable care for patients with chronic lymphocytic leukemia (CLL), understanding disparities as well as state and region-specific barriers that impact care is critical.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
As community care teams work to provide equitable care for patients with chronic lymphocytic leukemia (CLL), understanding disparities as well as state and region-specific barriers that impact care is critical. CANCER BUZZ speaks with Adam Kittai, MD, hematologist, and assistant professor at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute about ongoing research efforts to examine these disparities and ensuring equitable access to care for patients with CLL.
Guest
Adam Kittai, MD
Hematologist and Assistant Professor, Division of Hematology
The Ohio State University Comprehensive Cancer Center- The James
“In order to make a dent in cancer health equity, you need to have multi-level approach, including assessing what the problem is, implementing research that is small but additive, and focusing on the areas of the most unmet need. If we start to focus on the barriers that our patients experience, one patient at a time, we should be able to make a difference–if you focus on each patient in front of you and work on solving those barriers and [determining] reasons why they may not be getting equitable care as opposed to their cohorts.”
—Adam Kittai, MD
Resources:
This project is made possible by support from AstraZeneca, Janssen Oncology, and Pharmacyclics.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
September 10, 2026
In recognition of Leukemia and Lymphoma Awareness Month, ACCC compiled a group of resources to help care teams navigate two of the most commonly diagnosed adult leukemias: acute myeloid leukemia and chronic lymphocytic leukemia.
